-+ 0.00%
-+ 0.00%
-+ 0.00%

WEGOVY® (SEMAGLUTIDE INJECTION) RECEIVES CONDITIONAL MARKETING AUTHORIZATION FROM HEALTH CANADA AS THE FIRST AND ONLY TREATMENT FOR ADULTS WITH NON-CIRRHOTIC MASH, A SERIOUS LIVER DISEASE

路透·12/15/2025 12:01:10

登錄查看新聞詳情